These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 23913125)

  • 21. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of mtZFNs into Early Mouse Embryos.
    McCann BJ; Cox A; Gammage PA; Stewart JB; Zernicka-Goetz M; Minczuk M
    Methods Mol Biol; 2018; 1867():215-228. PubMed ID: 30155826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease.
    Srivastava S; Moraes CT
    Hum Mol Genet; 2001 Dec; 10(26):3093-9. PubMed ID: 11751691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels.
    Pereira CV; Bacman SR; Arguello T; Zekonyte U; Williams SL; Edgell DR; Moraes CT
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30012581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.
    Moraes CT; Atencio DP; Oca-Cossio J; Diaz F
    J Mol Diagn; 2003 Nov; 5(4):197-208. PubMed ID: 14573777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.
    Palculict ME; Zhang VW; Wong LJ; Wang J
    Methods Mol Biol; 2016; 1351():3-17. PubMed ID: 26530670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome.
    Rai PK; Craven L; Hoogewijs K; Russell OM; Lightowlers RN
    Essays Biochem; 2018 Jul; 62(3):455-465. PubMed ID: 29950320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High throughput single cell analysis of mitochondrial heteroplasmy in mitochondrial diseases.
    Maeda R; Kami D; Maeda H; Shikuma A; Gojo S
    Sci Rep; 2020 Jul; 10(1):10821. PubMed ID: 32616755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Mitochondria DNA Mutations in Diseases.
    Zhu Z; Wang X
    Adv Exp Med Biol; 2017; 1038():219-230. PubMed ID: 29178079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Manipulation of Human Mitochondrial DNA Heteroplasmy In Vitro Using Tunable mtZFN Technology.
    Gammage PA; Minczuk M
    Methods Mol Biol; 2018; 1867():43-56. PubMed ID: 30155814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.
    Tonin Y; Heckel AM; Vysokikh M; Dovydenko I; Meschaninova M; Rötig A; Munnich A; Venyaminova A; Tarassov I; Entelis N
    J Biol Chem; 2014 May; 289(19):13323-34. PubMed ID: 24692550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease.
    Shoop WK; Lape J; Trum M; Powell A; Sevigny E; Mischler A; Bacman SR; Fontanesi F; Smith J; Jantz D; Gorsuch CL; Moraes CT
    Nat Metab; 2023 Dec; 5(12):2169-2183. PubMed ID: 38036771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of unknown heteroplasmic mitochondrial DNA mutations with mismatch-specific surveyor nuclease.
    Bannwarth S; Procaccio V; Paquis-Flucklinger V
    Methods Mol Biol; 2009; 554():301-13. PubMed ID: 19513682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Mitochondrial DNA be CRISPRized: Pro and Contra.
    Loutre R; Heckel AM; Smirnova A; Entelis N; Tarassov I
    IUBMB Life; 2018 Dec; 70(12):1233-1239. PubMed ID: 30184317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altering the balance between healthy and mutated mitochondrial DNA.
    Smith PM; Lightowlers RN
    J Inherit Metab Dis; 2011 Apr; 34(2):309-13. PubMed ID: 20506041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inheritance of mitochondrial DNA in humans: implications for rare and common diseases.
    Wei W; Chinnery PF
    J Intern Med; 2020 Jun; 287(6):634-644. PubMed ID: 32187761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals.
    Ye K; Lu J; Ma F; Keinan A; Gu Z
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10654-9. PubMed ID: 25002485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of mitochondrial genome engineering.
    Silva-Pinheiro P; Minczuk M
    Nat Rev Genet; 2022 Apr; 23(4):199-214. PubMed ID: 34857922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.